Supply of chemotherapy drugs such
as Docetaxel
Public hearing - Thursday, 28 March 2013
Time: 11.15 am – 4.15 pm
Venue: Room 12+13, Cliftons
60 Margaret Street
Sydney
11.15am - 11.45am |
Cancer Voices Australia (Submission 18) |
11.45 am - 12.45 pm |
Pharmacy Guild of Australia (Submission 25)
Mr Stephen Armstrong
Clinical Oncology Society of Australia
(Submission 16)
Mr Dan Mellor - Chair of the COSA Cancer Pharmacists Group
Northern Cancer Institute (Submission 7)
Mr Tony Noun - Executive Chairman |
12.45 pm - 1.30 pm |
Society of Hospital Pharmacists in Australia
(Submission 6)
Mrs Suzanne Kirsa - President
Mrs Helen Dowling - Chief Executive Officer
Slade Pharmacy Services (Submission 9)
Mr David Slade - Managing Director
Mr Wayne Pertzel
APHS Pharmacy Group (Submission 31)
Mr Stuart Giles - Managing Partner and Executive Chairman |
1.30 pm - 2.00 pm |
Lunch |
2.00 pm - 2.45 pm |
Department of Health and Ageing
Mr David Learmonth - Deputy Secretary
Ms Felicity McNeill - First Assistant Secretary, Pharmaceutical Benefits Division |
2.45 pm - 3.15 pm |
Consumers Health Forum of Australia
(via teleconference)(Submission 22)
Ms Carol Bennett - Chief Executive Officer |
3.15 pm - 4.00 pm |
Integrated Clinical Oncology Network Cancer Care Board (Submission 19)
Dr Brett Robinson - Managing Director and Chief Executive Officer
Private Cancer Physicians of Australia and Medical Oncology Group Australia (Submission 17)
Dr John Bashford
Sydney Adventist Hospital - Pharmacy Services (Submission 15)
Dr Leon Clark - Chief Executive Officer
Mrs Margaret Duffy - Pharmacy/Corporate Services Executive Officer |
4.00pm - 4.15pm |
CanSpeak (Submission 14) |
4.15 pm |
Adjournment |
For further information, contact:
Committee Secretary
Senate Community Affairs References Committee
PO Box 6100
Parliament House
Canberra ACT 2600
Australia